KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is reviewing the phases of clinical trials for a new
medication. Which statement best describes a Phase III clinical
trial?
A. It determines the pharmacokinetics in healthy volunteers
B. It evaluates safety and dosage in a small group of patients
C. It compares the new drug to standard therapy in a large
population
D. It monitors long-term effects after the drug is marketed
Correct Answer: C
Rationale:
Phase III trials involve large populations and compare the new
drug to existing standard treatments to determine
effectiveness, monitor side effects, and collect data for safe use.
Option A describes Phase I trials. Option B describes Phase II
trials. Option D refers to Phase IV (post-marketing surveillance).
Question 2
A nurse explains therapeutic index to a patient starting a new
medication. Which description is most accurate?
A. The rate at which a drug is eliminated from the body
B. The ratio between the toxic dose and the effective dose
,C. The time required for a drug to reach peak concentration
D. The percentage of drug bound to plasma proteins
Correct Answer: B
Rationale:
The therapeutic index is the ratio between the toxic dose and
the effective dose, indicating drug safety. A narrow therapeutic
index means a higher risk of toxicity. Option A refers to
clearance, C refers to peak time, and D relates to protein
binding.
Question 3
A nurse is administering an oral medication with high first-pass
metabolism. What does this imply?
A. The drug is rapidly excreted by the kidneys
B. The drug is extensively metabolized in the liver before
reaching systemic circulation
C. The drug has increased bioavailability
D. The drug bypasses hepatic metabolism
Correct Answer: B
Rationale:
First-pass metabolism means the drug is significantly
metabolized in the liver before entering systemic circulation,
reducing its bioavailability. Option A is unrelated. Option C is
, incorrect because bioavailability is reduced. Option D is
incorrect because hepatic metabolism is involved.
Question 4
A patient asks why generic drugs are considered safe
alternatives to brand-name drugs. What is the nurse’s best
response?
A. Generic drugs are identical in color and shape to brand-name
drugs
B. Generic drugs have the same active ingredients and
therapeutic effects
C. Generic drugs are tested more rigorously than brand-name
drugs
D. Generic drugs have fewer side effects than brand-name drugs
Correct Answer: B
Rationale:
Generic drugs contain the same active ingredients, dosage
form, strength, and therapeutic effects as brand-name drugs.
They must demonstrate bioequivalence. Options A, C, and D are
incorrect because appearance may differ, testing standards are
comparable, and side effects are not necessarily fewer.
Question 5
A nurse is reviewing pharmacokinetics. Which process describes
the movement of a drug from the bloodstream into tissues?
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is reviewing the phases of clinical trials for a new
medication. Which statement best describes a Phase III clinical
trial?
A. It determines the pharmacokinetics in healthy volunteers
B. It evaluates safety and dosage in a small group of patients
C. It compares the new drug to standard therapy in a large
population
D. It monitors long-term effects after the drug is marketed
Correct Answer: C
Rationale:
Phase III trials involve large populations and compare the new
drug to existing standard treatments to determine
effectiveness, monitor side effects, and collect data for safe use.
Option A describes Phase I trials. Option B describes Phase II
trials. Option D refers to Phase IV (post-marketing surveillance).
Question 2
A nurse explains therapeutic index to a patient starting a new
medication. Which description is most accurate?
A. The rate at which a drug is eliminated from the body
B. The ratio between the toxic dose and the effective dose
,C. The time required for a drug to reach peak concentration
D. The percentage of drug bound to plasma proteins
Correct Answer: B
Rationale:
The therapeutic index is the ratio between the toxic dose and
the effective dose, indicating drug safety. A narrow therapeutic
index means a higher risk of toxicity. Option A refers to
clearance, C refers to peak time, and D relates to protein
binding.
Question 3
A nurse is administering an oral medication with high first-pass
metabolism. What does this imply?
A. The drug is rapidly excreted by the kidneys
B. The drug is extensively metabolized in the liver before
reaching systemic circulation
C. The drug has increased bioavailability
D. The drug bypasses hepatic metabolism
Correct Answer: B
Rationale:
First-pass metabolism means the drug is significantly
metabolized in the liver before entering systemic circulation,
reducing its bioavailability. Option A is unrelated. Option C is
, incorrect because bioavailability is reduced. Option D is
incorrect because hepatic metabolism is involved.
Question 4
A patient asks why generic drugs are considered safe
alternatives to brand-name drugs. What is the nurse’s best
response?
A. Generic drugs are identical in color and shape to brand-name
drugs
B. Generic drugs have the same active ingredients and
therapeutic effects
C. Generic drugs are tested more rigorously than brand-name
drugs
D. Generic drugs have fewer side effects than brand-name drugs
Correct Answer: B
Rationale:
Generic drugs contain the same active ingredients, dosage
form, strength, and therapeutic effects as brand-name drugs.
They must demonstrate bioequivalence. Options A, C, and D are
incorrect because appearance may differ, testing standards are
comparable, and side effects are not necessarily fewer.
Question 5
A nurse is reviewing pharmacokinetics. Which process describes
the movement of a drug from the bloodstream into tissues?
